U.S. FDA approves PADCEV plus Keytruda as neoadjuvant and adjuvant treatment for MIBC regardless of...

SOTIO receives FDA Fast Track Designation for CDH17-targeting ADC SOT109 for CRC

Hansoh Pharma announces ARTEMIS-008 trial achieved primary OS endpoint in SCLC

Kelun-Biotech’s phase 3 trial of Sac-TMT plus Pembrolizumab met the primary endpoint in 1L PD-L1-negative...

VERAXA Biotech and Ardigen collaborate to accelerate AI-enabled BiTAC pipeline development

Protina partners with Onconic Therapeutics on next-generation cancer drugs